CORPORATE EVENTS
March 17th, 2026 – Board of Directors’ meeting for the examination of the Financial Statements as of 31ˢᵗ December 2025.
April 27th, 2026 – Ordinary Shareholders’ meeting for the approval of the Financial Statements as of 31ˢᵗ December 2025.
May 11th, 2026 – Board of Directors’ meeting for the approval of the Interim Management Statements as of 31ˢᵗ March 2026.
September 11th, 2026 – Board of Directors’ meeting tfor the approval of the Half-Yearly Financial Report as of 30ᵗʰ June 2026.
November 9th, 2026 – Board of Directors’ meeting for the approval of the Interim Management Statements as of 30ᵗʰ September 2026.
COMMUNICATION OF REGULATED INFORMATION
Pharmanutra S.p.A. indicates that for the sending and storage of Regulated Information, use is made of the eMarket SDIR circulation system and the eMarket STORAGE mechanism managed by Spafid Connect S.p.A., with registered office in Foro Buonaparte 10, Milan.
